Menu Search
Equities

Sigma Healthcare Ltd

SIG:ASX

Sigma Healthcare Ltd

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (AUD)2.42
  • Today's Change0.10 / 4.31%
  • Shares traded4.67m
  • 1 Year change+253.44%
  • Beta0.2338
Data delayed at least 20 minutes, as of Nov 21 2024 05:10 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in AUDIncome statement in AUDView more

Year on year Sigma Healthcare Ltd had revenues fall -9.16% from 3.76bn to 3.42bn, though the company grew net income 148.98% from 1.81m to 4.51m.
Gross margin8.69%
Net profit margin-0.06%
Operating margin0.22%
Return on assets-0.15%
Return on equity-0.44%
Return on investment-0.25%
More ▼

Cash flow in AUDView more

In 2024, Sigma Healthcare Ltd increased its cash reserves by 2,648.83%, or 343.53m. Cash Flow from Financing totalled 295.83m or 8.66% of revenues. In addition the company generated 41.97m in cash from operations while cash from investing totalled 5.73m.
Cash flow per share0.0175
Price/Cash flow per share151.76
Book value per share0.5535
Tangible book value per share0.4839
More ▼

Balance sheet in AUDView more

Sigma Healthcare Ltd has a Debt to Total Capital ratio of 13.64%, a lower figure than the previous year's 43.60%.
Current ratio1.74
Quick ratio1.21
Total debt/total equity0.1582
Total debt/total capital0.1364
More ▼

Growth rates in AUD

Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked below the industry average relative to its peers.
Div yield(5 year avg)1.76%
Div growth rate (5 year)-21.93%
Payout ratio (TTM)--
EPS growth(5 years)-34.47
EPS (TTM) vs
TTM 1 year ago		-135.92
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.